News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
ESGO – Tumour Board Webinar: Mechanisms of Drug Resistance: PARP, ADC, Immunotherapy
ESGO/LinkedIn
Apr 18, 2025, 15:43

ESGO – Tumour Board Webinar: Mechanisms of Drug Resistance: PARP, ADC, Immunotherapy

European Society of Gynaecological Oncology (ESGO) posted on LinkedIn:

“Next week, Jonathan Ledermann and Damiano Arciuolo will speak at our Tumour Board webinar on the mechanisms of drug resistance: PARP, ADC, Immunotherapy.

He’ll be joined by our multidisciplinary experts and moderators Diana Bello Roufai, Upasana Palo, Houssein El Hajj, Richárd Tóth, Ana Tatiana Palacios Torres and Zoltan Novak. Please join!

Register via the ESGO eAcademy.

Daiichi Sankyo Europe has provided an independent medical educational grant towards this activity.”

Ana Tatiana Palacios Torres cancer Daiichi Sankyo Europe Damiano Arciuolo Diana Bello Roufai ESGO ESGO eAcademy Houssein El Hajj immunotherapy Jonathan Ledermann OncoDaily Oncology Richard Tóth Tumour Board webinar Upasana Palo Zoltan Novak
Special Coverage
Blog
Jul 10, 2025, 21:33
Today Marks the Beginning of Module 1 of the 2nd SIOP Europe Course in Paediatric Oncology
Blog
Jul 10, 2025, 21:24
At AACR25, Douglas Hanahan Showed That IL-1 Family Signaling Drives Systemic Immunosuppression in HPV Cancers
Blog
Jul 10, 2025, 21:13
Raelyn Was Just 4 Years Old When She Was Diagnosed With T-Cell Acute Lymphoblastic Leukemia - St. Baldrick's Foundation
Blog
Jul 10, 2025, 20:58
Janna Sisakyan: I Am Excited to Carry These Lessons Forward in My Future Medical Career
Blog
Jul 10, 2025, 20:44
We’re Excited to Announce That the First Patient Has Been Randomised in the PROLoNG Study - EORTC
Blog
Jul 10, 2025, 20:32
Paolo Tarantino: Incredibly Excited to Co-Chair the NRG Oncology Summer Symposium 2025
Blog
Jul 10, 2025, 20:21
Joshua Brody: Crystal-Clear Update on Treating Aggressive Lymphomas
Insight
Jul 10, 2025, 20:08
Pashtoon Kasi: The 1st Agnostic Study of a PARP Inhibitor
Drugs
Jul 10, 2025, 16:59
Taletrectinib (Ibtrozi): What Patients Should Know About in 2025?
Blog
Jul 10, 2025, 16:30
Indiana’s First Mobile Lung Screening Unit Proves That Access to Care Saves Lives - IU Simon Comprehensive Cancer Center
Blog
Jul 10, 2025, 16:24
Herbert Loong: Had an Opportunity to Introduce and Discuss Soft Tissue Sarcomas at Radio Television Hong Kong
Blog
Jul 10, 2025, 16:14
Sebastian Other-Gee Pohl Completed 2 Years of EACR-Boehringer Ingelheim Postdoctoral Fellowship